A. Akhmetshina, C. Dees, M. Pileckyte, B. Maurer, R. Axmann et al., Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis, The FASEB Journal, vol.22, issue.7, pp.2214-222207, 2008.
DOI : 10.1096/fj.07-105627

N. C. Andrews and D. V. Faller, A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells, Nucleic Acids Res, 1991.

K. Ashour, L. Shan, J. H. Lee, W. Schlicher, K. Wada et al., Bombesin Inhibits Alveolarization and Promotes Pulmonary Fibrosis in Newborn Mice, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.12, pp.1377-1385, 2005.
DOI : 10.1164/rccm.200507-1014OC

M. L. Biondi, B. Marasini, E. Bianchi, and A. Agostoni, Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon, International Journal of Cardiology, vol.19, issue.3, 1988.
DOI : 10.1016/0167-5273(88)90238-0

D. W. Bonhaus, C. Bach, A. Desouza, F. H. Salazar, B. D. Matsuoka et al., The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2b) receptor gene products: comparison with 5-HT2a and 5-HT2c receptors, British Journal of Pharmacology, vol.33, issue.4, pp.622-628, 1995.
DOI : 10.1111/j.1476-5381.1995.tb14977.x

S. Jähnichen, R. Horowski, and H. H. Pertz, Agonism at 5-HT2B receptors is not a class effect of the ergolines, European Journal of Pharmacology, vol.513, issue.3, pp.225-228, 2005.
DOI : 10.1016/j.ejphar.2005.03.010

A. Jüngel, O. Distler, U. Schulze-horsel, L. C. Huber, H. R. Ha et al., Microparticles stimulate the synthesis of prostaglandin E2 via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1, Arthritis & Rheumatism, vol.278, issue.11, pp.3564-3574, 2007.
DOI : 10.1002/art.22980

M. B. Kahaleh, I. Osborn, and E. C. Leroy, Elevated Levels of Circulating Platelet Aggregates and Beta-Thromboglobulin in Scleroderma, Annals of Internal Medicine, vol.96, issue.5, pp.610-613, 1982.
DOI : 10.7326/0003-4819-96-5-610

M. Kasho, M. Sakai, T. Sasahara, Y. Anami, T. Matsumura et al., Serotonin enhances the production of type IV collagen by human mesangial cells Katayama , I. , and K. Nishioka . 1997 . Substance P augments brogenic cytokine-induced broblast proliferation: possible involvement of neuropeptide in tissue brosis, Kidney Int. J. Dermatol. Sci, vol.5497, issue.15, pp.1083-1092, 1998.

A. F. Kheli, M. S. , and P. Salomoni, Daxx is required for stress-induced cell death and JNK activation . Cell Death Di er, pp.724-733, 2005.

A. Lawrie, E. Spiekerkoetter, E. C. Martinez, N. Ambartsumian, W. J. Sheward et al., Interdependent Serotonin Transporter and Receptor Pathways Regulate S100A4/Mts1, a Gene Associated With Pulmonary Vascular Disease, Circulation Research, vol.97, issue.3, pp.227-235, 2005.
DOI : 10.1161/01.RES.0000176025.57706.1e

E. C. Leroy and T. A. Medsger-jr, Criteria for the classi cation of early systemic sclerosis, J. Rheumatol, vol.28, pp.1573-1576, 2001.

R. A. Macdonald, S. L. Robbins, and G. K. Mallory, Dermal Fibrosis Following Subcutaneous Injections of Serotonin Creatinine Sulphate., Experimental Biology and Medicine, vol.97, issue.2, pp.334-337, 1958.
DOI : 10.3181/00379727-97-23734

C. Makridis, J. Rastad, K. Oberg, G. Akerström, P. et al., Progression of Metastases and Symptom Improvement from Laparotomy in Midgut Carcinoid Tumors, World Journal of Surgery, vol.20, issue.7, pp.900-906, 1995.
DOI : 10.1007/s002689900137

I. M. Modlin, M. D. Shapiro, M. Kidd-moertel, C. G. , W. G. Sauer et al., Carcinoid tumors and brosis: an association with no explanation Life history of the carcinoid tumor of the small intestine A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome Serotonin 2B receptor is required for heart development, 1<33::AID-CNCR2820670107>3.0.CO Proc. Natl. Acad. Sci. USA, pp.2466-2478, 1961.

J. A. Obeso, J. C. Rothwell, N. P. Quinn, A. E. Lang, J. Artieda et al., Lisuride in the treatment of myoclonus, Adv. Neurol, vol.43, pp.191-196, 1986.

M. Pavlovic, P. Saiag, J. P. Lotz, E. Marinho, T. Clerici et al., Regression of sclerodermatous skin lesions in a patient with carcinoid syndrome treated by octreotide, Archives of Dermatology, vol.131, issue.10, pp.1207-1209, 1995.
DOI : 10.1001/archderm.131.10.1207

A. E. Postlethwaite and T. M. Chiang, Platelet contributions to the pathogenesis of systemic sclerosis, Current Opinion in Rheumatology, vol.19, issue.6, pp.574-579, 2007.
DOI : 10.1097/BOR.0b013e3282eeb3a4

E. Reimund, Methysergide and retroperitoneal brosis, pp.140-673690140, 1987.

B. L. Roth, Drugs and Valvular Heart Disease, New England Journal of Medicine, vol.356, issue.1, pp.6-9, 2007.
DOI : 10.1056/NEJMp068265

J. Czuwara-ladykowska, F. Shirasaki, P. Jackers, D. K. Watson, M. Trojanowska et al., Fli-1 inhibits collagen type I production in dermal broblasts via an Sp1-dependent pathway Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis broblasts via nuclear factor-kappaB and simian virus 40 promoter factor 1 pathways, J. Biol. Chem. Mol. Pharmacol, vol.276, issue.65, pp.20839-20848, 2001.

J. H. Distler, A. Jüngel, L. C. Huber, C. A. Seemayer, C. F. Reich et al., The induction of matrix metalloproteinase and cytokine expression in synovial broblasts stimulated with immune cell microparticles, Proc. Natl. Acad. Sci. USA, pp.2892-2897, 2005.

J. H. Distler, A. Jüngel, L. C. Huber, U. Schulze-horsel, J. Zwerina et al., Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis, Arthritis & Rheumatism, vol.24, issue.1, pp.311-322, 2007.
DOI : 10.1002/art.22314

J. H. Distler, A. Jüngel, M. Pileckyte, J. Zwerina, B. A. Michel et al., Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis, Arthritis & Rheumatism, vol.7, issue.12, pp.4203-4215, 2007.
DOI : 10.1002/art.23074

O. Distler, A. Del-rosso, R. Giacomelli, P. Cipriani, M. L. Conforti et al., Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of ngertip ulcers, Arthritis Research, vol.4, issue.6, pp.11-21, 2002.
DOI : 10.1186/ar596

A. Fabre, J. Marchal-sommé, S. Marchand-adam, C. Quesnel, R. Borie et al., Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice, European Respiratory Journal, vol.32, issue.2, pp.426-436, 2008.
DOI : 10.1183/09031936.00126907

J. F. Fries, J. A. Lindgren, and J. M. Bull, Scleroderma-like Lesions and the Carcinoid Syndrome, Archives of Internal Medicine, vol.131, issue.4, pp.550-553, 1973.
DOI : 10.1001/archinte.1973.00320100078010

A. Gabrielli, E. V. Avvedimento, T. Krieg, E. , and H. H. Pertz, Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B) receptors, Scleroderma . N. Engl. J. Med. Br. J. Pharmacol, vol.360, issue.130, pp.692-698, 1989.

S. C. Goldberg, K. A. Halmi, E. D. Eckert, R. C. Casper, and J. M. Davis, Cyproheptadine in anorexia nervosa, The British Journal of Psychiatry, vol.134, issue.1, pp.67-70, 1979.
DOI : 10.1192/bjp.134.1.67

M. C. Green, H. O. Sweet, and L. E. Bunker, Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton, Am. J. Pathol, vol.82, pp.493-512, 1976.

B. I. Gustafsson, K. Tømmerås, I. Nordrum, J. P. Loennechen, A. Brunsvik et al., Long-Term Serotonin Administration Induces Heart Valve Disease in Rats, Circulation, vol.111, issue.12, pp.1517-1522, 2005.
DOI : 10.1161/01.CIR.0000159356.42064.48

A. Hallen, FIBROSIS IN THE CARCINOID SYNDROME, The Lancet, vol.283, issue.7336, pp.746-747, 1964.
DOI : 10.1016/S0140-6736(64)92853-3

P. Hervé, J. M. Launay, M. L. Scrobohaci, F. Brenot, G. Simonneau et al., Increased plasma serotonin in primary pulmonary hypertension, The American Journal of Medicine, vol.99, issue.3, 1995.
DOI : 10.1016/S0002-9343(99)80156-9

C. Hofmann, U. Penner, R. Dorow, H. H. Pertz, S. Jähnichen et al., Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties, Clinical Neuropharmacology, vol.29, issue.2, pp.80-86, 2006.
DOI : 10.1097/00002826-200603000-00005

P. P. Humphrey, P. Hartig, and D. Hoyer, A proposed new nomenclature for 5-HT receptors, Trends in Pharmacological Sciences, vol.14, issue.6, pp.233-236, 1993.
DOI : 10.1016/0165-6147(93)90016-D

R. B. Rothman, M. H. Baumann, J. E. Savage, L. Rauser, A. Mcbride et al., Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications, Circulation, vol.102, issue.23, pp.2836-2841, 2000.
DOI : 10.1161/01.CIR.102.23.2836

R. G. Ruddell, F. Oakley, Z. Hussain, I. Yeung, L. J. Bryan-lluka et al., A Role for Serotonin (5-HT) in Hepatic Stellate Cell Function and Liver Fibrosis, The American Journal of Pathology, vol.169, issue.3, pp.861-876050767, 2006.
DOI : 10.2353/ajpath.2006.050767

V. Setola, S. J. Hufeisen, K. J. Grande-allen, I. Vesely, R. A. Glennon et al., Ecstasy " ) induces fen uramine-like proliferative actions on human cardiac valvular interstitial cells in vitro, Mol. Pharmacol, vol.3, issue.63, pp.4-1223, 2003.

R. Sgonc, M. S. Gruschwitz, H. Dietrich, H. Recheis, M. E. Gershwin et al., Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma., Journal of Clinical Investigation, vol.98, issue.3, pp.785-792, 1996.
DOI : 10.1172/JCI118851

Y. Soma, K. Takehara, S. Sato, and Y. Ishibashi, Increase in plasma thrombomodulin in patients with systemic sclerosis, J. Rheumatol, vol.20, pp.1444-1445, 1993.

A. Stachów, S. Jab?o, and A. Skiendzielewska, Biogenic amines derived from tryptophan in systemic and cutaneous scleroderma, Acta Derm. Venereol, vol.59, pp.1-5, 1979.

V. D. Steen and T. A. Medsger, Changes in causes of death in systemic sclerosis, 1972-2002, Annals of the Rheumatic Diseases, vol.66, issue.7, pp.940-944, 1972.
DOI : 10.1136/ard.2006.066068

R. M. Strieter and B. Mehrad, New Mechanisms of Pulmonary Fibrosis, Chest, vol.136, issue.5, pp.1364-1370, 2009.
DOI : 10.1378/chest.09-0510

A. Szegedi and N. Schwertfeger, Mirtazapine: a review of its clinical efficacy and tolerability, Expert Opinion on Pharmacotherapy, vol.5, issue.1, pp.631-641, 2005.
DOI : 10.1016/S0885-3924(02)00645-0

J. Varga, D. Abraham-von-werner, K. , K. Gräf, A. Scholz et al., Systemic sclerosis, Therapy with terguride . Nichidoku-Iho, pp.557-567, 1989.
DOI : 10.1016/B978-0-323-04404-2.10055-7

URL : https://hal.archives-ouvertes.fr/hal-01256047

D. J. Walther, J. U. Peter, S. Bashammakh, H. Hörtnagl, M. Voits et al., Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform, Science, vol.299, issue.5603, 2003.
DOI : 10.1126/science.1078197

M. Ahnert-hilger and . Bader, Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release, Cell, vol.115, issue.03, pp.851-862, 2003.

S. Wang, M. C. Wilkes, E. B. Leof, R. Hirschberg-woessner, and J. F. Jr, Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal brogenesis in vivo The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid, FASEB J. Arch. Biochem. Biophys, vol.19, issue.9361, pp.1-11, 1961.

M. M. Wouters, S. J. Gibbons, J. L. Roeder, M. Distad, Y. Ou et al., Exogenous Serotonin Regulates Proliferation of Interstitial Cells of Cajal in Mouse Jejunum Through 5-HT2B Receptors, Gastroenterology, vol.133, issue.3, pp.897-906, 2007.
DOI : 10.1053/j.gastro.2007.06.017

C. J. Zarafonetis, S. H. Lorber, and S. M. Hanson, ASSOCIATION OF FUNCTIONING CARCINOID SYNDROME AND SCLERODERMA. I. CASE REPORT, The American Journal of the Medical Sciences, vol.236, issue.1, 1958.
DOI : 10.1097/00000441-195807000-00001